The European medical cannabis market is growing steadily. Many EU countries are rethinking their respective cannabis policies and adjusting laws for the distribution of medical cannabis as an alternative medicine. Countries like the Netherlands, Denmark and Portugal position themselves as strong growing regions, whereas other EU countries focus on distribution.
After legalization in March 2017, Germany established itself as one of the world’s largest distribution markets for medical cannabis.
In 2018, 60,000 patients in Germany had received prescription medical cannabis. The number of prescriptions is expected to increase enormously over the next ten years.
The years of dependence on North American suppliers will end with the products manufactured in Europe by the end of 2020.
Based on these market trends, Ilios Santé GmbH has entered into valuable partnerships with European companies in the areas of cultivation, production, refinement, and logistics services for cannabis products – with the primary goal in mind: to improve the lives of patients across Europe.